CIK 0001516551
- Non-accelerated filer
- Smaller reporting company
Skye Bioscience, Inc.
Sign in to watch- Ticker
- SKYE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 450692882
- Phone
- +1 858-410-0266
- Business address
- 11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
- Former names
- Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $613,506
- in 6 filings
Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-25 | TYLE PRAVEEN Director | Grant or award · Stock Option (Right to Buy) | +1,472,692 | 1,472,692 | ||
| 2023-08-25 | DALESANDRO MARGARET Director | Grant or award · Stock Option (Right to Buy) | +1,472,692 | 1,472,692 | ||
| 2023-08-25 | Ward Keith Wayne Director | Grant or award · Stock Option (Right to Buy) | +1,472,692 | 1,472,692 | ||
| 2023-08-25 | Charych Deborah H. Director | Grant or award · Stock Option (Right to Buy) | +1,472,692 | 1,472,692 | ||
| 2023-08-23 | DHILLON PUNIT Chief Executive Officer | Other acquisition | +9,000 | $0.01 | $106 | 24,692,957 |
| 2023-08-23 | DHILLON PUNIT Chief Executive Officer | Other acquisition | +9,000 | $0.01 | $106 | 40,563,828 |
| 2023-08-18 | Schwab Andrew J. Director | Grant or award | +267,602,039 | 267,602,039 | ||
| 2023-08-18 | Schwab Andrew J. Director | Grant or award | +10,558,878 | 10,558,878 | ||
| 2023-08-18 | Schwab Andrew J. Director | Grant or award | +684,361,447 | $0.01 | $7.0M | 684,361,447 |
| 2023-08-18 | Schwab Andrew J. Director | Grant or award | +161,944,872 | $0.01 | $1.7M | 429,546,911 |
| 2023-08-18 | Schwab Andrew J. Director | Grant or award | +6,389,921 | $0.01 | $66K | 16,948,799 |
| 2023-08-18 | Schwab Andrew J. Director | Grant or award · Warrant (Right to Buy) | +426,348,120 | 426,348,120 | ||
| 2023-02-22 | Emerald Health Sciences Inc. 10% owner | Grant or award | +16,641,486 | $0.02 | $283K | 128,028,737 |
| 2023-02-22 | Emerald Health Sciences Inc. 10% owner | Grant or award | +41,379,164 | $0.04 | $1.6M | 169,407,901 |
| 2023-02-22 | Emerald Health Sciences Inc. 10% owner | Returned to the company · Warrants | −9,141,486 | 0 | ||
| 2023-02-22 | Emerald Health Sciences Inc. 10% owner | Purchase · Warrants with Credit Facility of Oct 5, 2018 | −2,500,000 | 0 | ||
| 2023-02-22 | Emerald Health Sciences Inc. 10% owner | Returned to the company · Warrants with Credit Facility of Oct 5, 2018 - T2 | −2,500,000 | 0 | ||
| 2023-02-22 | Emerald Health Sciences Inc. 10% owner | Returned to the company · Warrants with Credit Facility of Oct 5, 2018 - T3 | −2,500,000 | 0 | ||
| 2023-02-14 | Charych Deborah H. Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2023-01-05 | TYLE PRAVEEN Director | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 |
Page 10 of 15 · 292 trades